Full Text View
Tabular View
No Study Results Posted
Related Studies
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
This study has been completed.
Study NCT00050817   Information provided by Sanofi-Aventis
First Received: December 20, 2002   Last Updated: March 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arteriosclerosis
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
clopidogrel (SR25990)
Additional drug interventions recognized in this trial
Clopidogrel
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services